Review
doi: 10.1038/nrd913.
G-protein-coupled receptor oligomerization and its potential for drug discovery
Affiliations
- PMID: 12360258
- DOI: 10.1038/nrd913
Item in Clipboard
Review
G-protein-coupled receptor oligomerization and its potential for drug discovery
Nat Rev Drug Discov.
2002 Oct.
Abstract
G-protein-coupled receptors (GPCRs) represent by far the largest class of _targets for modern drugs. Virtually all therapeutics that are directed towards GPCRs have been designed using assays that presume that these receptors are monomeric. The recent realization that these receptors form homo-oligomeric and hetero-oligomeric complexes has added a new dimension to rational drug design. However, this important aspect of GPCR biology remains largely unincorporated into schemes to search for new therapeutics. This review provides a synopsis of the current thinking surrounding GPCR homo-oligomerization and hetero-oligomerization and shows how new models point towards unexplored avenues in the development of new therapies.
Similar articles
-
Modeling the 3D structure of GPCRs: advances and application to drug discovery.Curr Opin Drug Discov Devel. 2003 May;6(3):353-61. Curr Opin Drug Discov Devel. 2003. PMID: 12833668 Review.
-
Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences.Biochem J. 2002 Jul 15;365(Pt 2):429-40. doi: 10.1042/BJ20020251. Biochem J. 2002. PMID: 11971762 Free PMC article.
-
The use of constitutively active GPCRs in drug discovery and functional genomics.Nat Rev Drug Discov. 2002 Aug;1(8):599-608. doi: 10.1038/nrd872. Nat Rev Drug Discov. 2002. PMID: 12402500 Review.
-
Formation of oligomers by G protein-coupled receptors.Curr Opin Drug Discov Devel. 2002 Sep;5(5):756-63. Curr Opin Drug Discov Devel. 2002. PMID: 12630296 Review.
-
GPCR-GIP networks: a first step in the discovery of new therapeutic drugs?Curr Opin Drug Discov Devel. 2004 Sep;7(5):649-57. Curr Opin Drug Discov Devel. 2004. PMID: 15503867 Review.
Cited by
-
G-protein coupled receptor 83 (GPR83) signaling determined by constitutive and zinc(II)-induced activity.PLoS One. 2013;8(1):e53347. doi: 10.1371/journal.pone.0053347. Epub 2013 Jan 15. PLoS One. 2013. PMID: 23335960 Free PMC article.
-
Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5.Mol Cancer. 2013 Jun 18;12:64. doi: 10.1186/1476-4598-12-64. Mol Cancer. 2013. PMID: 23773523 Free PMC article.
-
Curvature and hydrophobic forces drive oligomerization and modulate activity of rhodopsin in membranes.Biophys J. 2006 Dec 15;91(12):4464-77. doi: 10.1529/biophysj.106.082776. Epub 2006 Sep 29. Biophys J. 2006. PMID: 17012328 Free PMC article.
-
Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.J Med Chem. 2010 Oct 14;53(19):7048-60. doi: 10.1021/jm1006676. J Med Chem. 2010. PMID: 20845959 Free PMC article.
-
Molecular organization and dynamics of the melatonin MT₁ receptor/RGS20/G(i) protein complex reveal asymmetry of receptor dimers for RGS and G(i) coupling.EMBO J. 2010 Nov 3;29(21):3646-59. doi: 10.1038/emboj.2010.236. Epub 2010 Sep 21. EMBO J. 2010. PMID: 20859254 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
